1-5 of 5
J Palmer
Close
Sort by
Journal Articles

Outcomes for Unrelated Donor Hematopoietic Cell Transplantation (URD-HCT) for Patients with Acute Lymphoblastic Leukemia (ALL) Using Fractionated Total Body Irradiation (FTBI) and Etoposide (VP16).

Margaret O’Donnell, P Parker, A Dagis, ML Slovak, D Snyder, A Stein, R. Spielberger, A Pawlowska, J Rosenthal, J Palmer, N. Kogut, S. J Forman
Journal: Blood
Blood (2008) 112 (11): 3286.
https://doi.org/10.1182/blood.V112.11.3286.3286
Published: 2008
Journal Articles

Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation for High-Risk Acute Lymphoblastic Leukemia: A Potential Therapeutic Approach for High Risk ALL Patients Not Eligible for Full Intensity Transplantation

A. Stein, J Palmer, M O’Donnell, N. Kogut, R Spielberger, ML Slovak, NC Tsai, S. J Forman
Journal: Blood
Blood (2008) 112 (11): 4321.
https://doi.org/10.1182/blood.V112.11.4321.4321
Published: 2008
Journal Articles

Clinical Outcomes of Patients with T Cell NHL Undergoing Allogeneic Stem Cell Transplant.

Jasmine Zain, MD, J. Palmer, Ph.D, N. Tsai, L. Popplewell, M.D., A. Nadamanee, M.D., A. Krishnan, M.D., R. Nakamura, M.D., R. Rodriguez, M.D., S. J. Forman, M.D., M. Kirschbaum, M.D.
Journal: Blood
Blood (2006) 108 (11): 3026.
https://doi.org/10.1182/blood.V108.11.3026.3026
Published: 2006
Journal Articles

Long Term Survival after ASCT for AML: Multivariate Analysis Shows Adverse Effect of Collecting and Infusing Larger Numbers of CD 34 Positive Cells.

Clarence B. Sarkodee-Adoo, MD, FACP, Anthony S. Stein, MD, Margaret R. O’Donnell, MD, Ravi M. Bhatia, MD, E. Bolotin, MD, K. P. Chang, MD, Mark Kirschbaum, MD, Neil Kogut, MD, Auayporn Nademanee, MD, Pablo Parker, MD, Vinod Pullarkat, MD, David Snyder, MD, Ricardo Spielberger, MD, Marilyn L. Slovak, MD, Joseph Alvarnas, MD, Joy Fridey, MD, Jeffrey Schriber, MD, Eileen Smith, MD, Andy Dagis, J. Land, J. Palmer, N. Vora, Stephen Forman, MD FACP
Journal: Blood
Blood (2005) 106 (11): 2921.
https://doi.org/10.1182/blood.V106.11.2921.2921
Published: 2005
Journal Articles

Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) - a 15 Year Experience.

Anthony Selwyn Stein, MD, M. O’Donnell, MD, P. Parker, MD, R. Spielberger, MD, A. Nademanee, MD, R. Bhatia, MD, D. S. Snyder, MD, M. Kirschbaum, MD, V. Pullarkat, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, C. Sarkodee-Adoo, MD, M. Slovak, MD, N. Vora, MD, J. Land, RN, A. Dagis, J. Palmer, S. J. Forman, MD
Journal: Blood
Blood (2004) 104 (11): 1870.
https://doi.org/10.1182/blood.V104.11.1870.1870
Published: 2004